What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Morphine Market Size, Share, Growth and Industry Analysis by Type (Oral Tablets, Injection, And, Capsule), By Application (Anesthesia, Cough Suppressant, and Diarrhea Suppressant), Regional Insights, and Forecast From 2025 To 2034
Buy Now
Trending Insights
Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities
Our Research is the Cornerstone of 1000 Firms to Stay in the Lead
1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
MORPHINE MARKET OVERVIEW
The global Morphine Market size stood at USD 33.71 billion in 2025, growing further to USD 66.94 billion by 2034 at an estimated CAGR of 7.92% from 2025 to 2034.
The United States Morphine Market size is projected at USD 11.59152 billion in 2025, the Europe Morphine Market size is projected at USD 9.63657 billion in 2025, and the China Morphine Market size is projected at USD 7.61083 billion in 2025.
Morphine is a drug that is derived from opium. It is a strong opiate, and is a dark brown resin. This substance can be used as medication. When an overdose of this substance is taken, it can lead to side effects, and addiction. Morphine is used in small quantities in various medications in the healthcare sector.
Recently a lot of people are suffering from inflammatory diseases. Arthritis, elbow, and knee pain have become very common in people. Morphine is being used as an effective pain killer to treat these ailments. This is considered as the latest trend in the market.
This medication can also be used post-surgery as it is very helpful in removing the pain from the central nervous system. Additionally, it is also used to treat cancer. All of these factors have played an important role in increasing the morphine market share.
KEY FINDINGS
- Market Size and Growth: USD 33.71 billion in 2025, growing further to USD 66.94 billion by 2034 at an estimated CAGR of 7.92% from 2025 to 2034.
- Key Market Driver: over 70% of cancer deaths occur in low- and middle-income countries, driving demand for opioid analgesics including morphine.
- Major Market Restraint: ~80% of the world’s population consumes only ~14% of morphine used for pain management, constraining global access.
- Emerging Trends: since 2015 global manufacture of morphine has shown a downward trend, concentrating supply in a few countries.
- Regional Leadership: North America where per-country S-DDD rates often exceed 100 S-DDD per million per day versus single-digit rates in many low-income regions.
- Competitive Landscape:several companies operate dozens of manufacturing sites or thousands of employees globally
- Market Segmentation: Injectables, oral solutions, and controlled-release tablets, with injectables representing a critical share for hospital/surgical use.
- Recent Development: Declines in morphine manufacture in 2022 and ongoing unequal access—prompting several national policy responses to revise procurement or cultivation policies.
COVID-19 IMPACT
Growth of Healthcare Sector During Pandemic Increased Market Growth
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
The pandemic of COVID-19 was the primary reason for the downfall of several markets. Unavailability of labor, raw materials, and lockdowns were the major cause of disruption in the working of certain industries. Despite the COVID conditions some industries managed to survive and grow.
Life support products and the healthcare sector saw tremendous growth and demand during the pandemic period. Many people suffered from infections, respiratory diseases, and COVID conditions during pandemic. Therefore, it became highly necessary for people to approach the medical industry to cure their diseases. Morphine is a substance that is frequently used in the medical market. With the growth of the healthcare industry, the morphine market also developed during the pandemic.
LATEST TRENDS
Effective Pain-Relieving Features of This Drug to Increase Market Growth
Morphine is considered to be one among the most effective pain killers compared to other drugs. When a patient is administered with this drug, it starts to relieve the pain immediately. Because of this feature it is used in the preparation of several pain killer tablets.
Apart from being used as a primary substance in most of the pain killing medicines, it is also used to treat and cure chronic pain which is usually seen under highly complex and advanced medical conditions. Effective pain-relieving feature of this drug is prone to help in the morphine market growth.
- Supply concentration:Our reports that ~82% of the global population has access to less than 17% of morphine-based medicines, underscoring geographic supply concentration.
- Consumption disparity: Studies show the average controlled opioid consumption was ~32 mg/person/year in certain comparative analyses.
MORPHINE MARKET SEGMENTATION
-
By Type
The market can be divided on the basis of type into the following segments:
Oral tablets, injection, and, capsule. The oral tablets segment is projected to hold the dominant market share through 2028 the forecasting period.
-
By Application
The market can be divided on the basis of application into the following segments:
Anesthesia, cough suppressant, and, diarrhea suppressant. Anesthesia segment is predicted to dominate the market through 2028.
DRIVING FACTORS
Increasing Cases of Orthopedic Ailments to Amplify Market Growth
From the past few decades several people are being diagnosed with severe orthopedic ailments. The changing lifestyle, and lack of exercise can be the main reason for such ailments. Arthritis, fibromyalgia, elbow pain, knee pain, and osteoporosis are some of the most commonly seen orthopedic diseases among people.
Such ailments are more prevalent in the middle-aged and old-aged people. Morphine is widely regarded as a reliable medication for such orthopedic diseases. As it has the ability to effectively relieve the pain, doctors prescribe using this drug to their patients. This can be considered as one of the main factors driving the market growth and development.
Usage of Morphine Post Surgery to Drive Market Growth
The main use of this drug is to quickly relieve pain. Therefore, it is also being adopted to be administered to patients post their surgery to reduce the level of pain. It is also used for treating complex medical conditions like cancer.
Several technological advancements have taken place in the health sector and this has increased the awareness among people about taking the right treatment. Morphine which is narcotic analgesic has the power to ease the pain in the central nervous system because of which it is used after the surgeries. This factor has contributed in the growth of the market share.
- Clinical convenience: Adoption of twice-daily morphine dosing (introducing MS Contin in 1987) improved patient compliance in chronic pain therapy .
- Essential medicine status: WHO classifying morphine as a “gold standard” analgesic emphasizes its irreplaceable role in treating moderate-to-severe pain .
RESTRAINING FACTOR
Sedative and Addictive Nature of This Substance to Deteriorate Market Growth
Rather than being known as a good medication, morphine is well-known as a drug. This is mainly due to its sedative and addictive nature. An overdose of the drug can result in addiction. Once a person gets addicted to using this, it will be very difficult to break the addiction.
Morphine has the potential to be used for drug abuse as it is euphoric in nature. Another factor that can hamper the market growth is the introduction of new kind of generic medicines that can replace this drug as a pain killer. All of these factors can deteriorate the market dynamics.
- Regulatory barriers: In low-income countries, restrictive narcotics policies limit morphine penetration, as shown by 97 % drop in India post-1985 legislation .
- Access inequality: Just 13 % of global morphine is consumed by 79 % of the population living in lower-income nations, per INCB .
-
Request a Free sample
to learn more about this report
MORPHINE MARKET REGIONAL INSIGHTS
North America to Dominate Market in Upcoming Years
North America is considered to be the leading share holder of the market during the research period. This is due to the growing cases of orthopedic ailments and other inflammatory diseases. People suffering from such conditions take pain killers that contain some amount of morphine in it.
Several countries release large amount of funds for conducting researches and studies in the medical and healthcare sector. Similarly, fundings are being made into this market as well to study the additional uses of this drug. These factors have led to the development of market in North America.
KEY INDUSTRY PLAYERS
Leading Players adopt Acquisition Strategies to Stay Competitive
Several players in the market are using acquisition strategies to build their business portfolio and strengthen their market position. In addition, partnerships and collaborations are among the common strategies adopted by companies. Key market players are making R&D investments to bring advanced technologies and solutions to the market.
- Mallinckrodt Pharmaceuticals: Mallinckrodt remains one of the foremost suppliers of controlled-release morphine formulations, under continuous FDA oversight .
- Purdue Pharma — legacy company founded in 1892, historically a major US opioid manufacturer and widely referenced in regulatory/legal material.
List of Top Morphine Companies
- Mallinckrodt Pharmaceuticals
- Purdue Pharma
- Johnson Matthey Fine Chemicals
- Sanofi Winthrop Industries
- Pfizer Inc.
- Tai Pharmaceuticals Limited
- Qinghai Pharmaceutica
- Northeast Pharmaceutical Group
- Daiichi Sankyo Inc
- Mayne Pharma Group Limited
- Macfarlan Smith
- Manus Aktteva Biopharma LLP
- Verve Health Care Ltd.
- Sun Pharmaceutical Industries
- Alcaliber
REPORT COVERAGE
The report provides an insight into industry from both the demand and supply sides. Further, it also gives information on the impact of COVID-19 on the market, the driving and the restraining factors along with the regional insights. Market dynamic forces during the forecast period have also been discussed for the better understanding of the market situations. The report also lists the key industry players to understand the competition.
| Attributes | Details |
|---|---|
|
Market Size Value In |
US$ 33.71 Billion in 2025 |
|
Market Size Value By |
US$ 66.94 Billion by 2034 |
|
Growth Rate |
CAGR of 7.92% from 2025 to 2034. |
|
Forecast Period |
2025TO2034. |
|
Base Year |
2024 |
|
Historical Data Available |
Yes |
|
Regional Scope |
Global |
|
Segments Covered |
|
|
By Types
|
|
|
By Application
|
FAQs
The Morphine Market is expected to reach USD 66.94 billion by 2034.
The Morphine Market is expected to exhibit a CAGR of 7.92% by 2034.
The Morphine Market is USD 33.71 billion in 2025.
The Morphine Market is segmented by Type Injection, Oral, Other Dosage Forms And Application Hospitals & Clinics, Ambulatory Surgical Centers, Others
North America leads the market
Mallinckrodt Pharmaceuticals, Purdue Pharma, Johnson Matthey Fine Chemicals, Sanofi Winthrop Industries, Pfizer Inc., Tai Pharmaceuticals Limited, Qinghai Pharmaceutica, Northeast Pharmaceutical Group, Daiichi Sankyo Inc, Mayne Pharma Group Limited, Macfarlan Smith, Manus Aktteva Biopharma LLP, Verve Health Care Ltd., Sun Pharmaceutical Industries, Alcaliber the top companies operating in the Morphine Market.
